diphenethyl-malonic acid | 86310-45-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: diphenethyl-malonic acid
• 英文别名: Diphenaethyl-malonsaeure；1.5-Diphenyl-pentan-dicarbonsaeure-(3.3)；Di-β-phenaethyl-malonsaeure；2,2-bis(phenethyl)malonic acid；bis(2-phenylethyl)malonic acid；2,2-bis(2-phenylethyl)propanedioic acid
• CAS: 86310-45-4
• 化学式: C₁₉H₂₀O₄
• 分子量: 312.365
• InChiKey: LKYFYQXPFFFDCD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  23
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  diphenethyl-malonic acid 在 氯仿 、 五氯化磷 作用下， 生成 2-phenethyl-3,4-dihydro-2H-naphthalen-1-one
  参考文献：
  名称：

  Leuchs, Justus Liebigs Annalen der Chemie, 1928, vol. 461, p. 40

  摘要：

  DOI：
• 作为产物：
  描述：

  diethyl 2,2-diphenethylmalonate 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 生成 diphenethyl-malonic acid
  参考文献：
  名称：

  Role of substituents in copper(II) extraction with N,N′-bis(8-quinolyl)malonamides

  摘要：

  It has been found that substituents on N,N'-bis(8-quinolyl)malonamide play an important role in copper(II) extraction: among the substituents studied, benzyl groups dramatically increased extractability of the malonamide complex. The role of substituents is discussed on the basis of the results of titration and H-1 NMR measurements of copper(II) or nickel(II) complexes as well as copper(II)-extraction experiments. Intramolecular interactions between pi electrons of the benzyl group and the metal centre of the complex are proposed to occur.

  DOI：

  10.1039/dt9920002679

文献信息

• CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
  申请人：Aymami Bofarull Juan

  公开号：US20110105544A1

  公开（公告）日：2011-05-05

  The invention provides novel compounds of formula (I), wherein: R 1 is a radical derived from one of the known ring systems; R 2 is a phenyl radical optionally substituted; X n represents a birradical selected from the group consisting of: —(CH 2 ) 1-4 —, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )alkynyl, —S—(CH 2 ) 1-3 —#, and —(CH 2 ) 1-3 —O—#; wherein the symbol # indicates the position at which X n is attached to R 1 ; Y n is a birradical selected from the group consisting of: —(CH 2 ) 2-4 —, —S—(CH 2 ) 1-3 #, and —O—(CH 2 ) 1-3 —#; wherein the symbol # indicates the position at which Y n is attached to R 2 ; and R 3 is a radical selected from the group consisting of: —OR 4 . The compounds of formula (I) are useful in the treatment of cancer.

  本发明提供了式（I）的新化合物，其中：R1是从已知环系中派生的基团；R2是可选取代的苯基基团；Xn代表从以下群组中选择的双基团：—（CH2）1-4—，（C2-C4）-烯基，（C2-C4）炔基，—S—（CH2）1-3—#，和—（CH2）1-3—O—#；其中符号#表示Xn连接到R1的位置；Yn代表从以下群组中选择的双基团：—（CH2）2-4—，—S—（CH2）1-3#，和—O—（CH2）1-3—#；其中符号#表示Yn连接到R2的位置；R3是从以下群组中选择的基团：—OR4。式（I）的化合物在癌症治疗中有用。
• Histidine derivatives as renin inhibitors
  申请人：Kissei Pharmaceutical Co Ltd

  公开号：EP0181110A2

  公开（公告）日：1986-05-14

  @ Dipeptides are described which are represented by the formula wherein His represents an L-histidyl group, Ar, represents a phenyl group, a naphthyl group or an indolyl group, Ar2 represents a phenyl group or a naphthyl group, X represents a chemical bond, -NHCO-, -CONH-, -CO-, -CH2-, -NH-, -O- or -(CH=CH)P-wherein p is 1 or 2, Z represents an oxygen atom or in which R2 represents a hydrogen atom or combines with R, to form a chemical bond, m and n, which may be the same or different, each represents an integer of from 0 to 3, provided that when X is a chemical bond, the sum of n plus m is from 1 to 6 and when X is not a chemical bond, the sum of n plus m is from 1 to 4, Y represents a chemical bond when X is not a chemical bond, or, when X is a chemical bond, an alkylene group having 1 to 3 carbon atoms, R1 represents a hydrogen atom or combines with R2 to form a chemical bond, R3 represents a formyl group or a hydroxymethyl group, R4 represents an isobutyl group or a benzyl group, and C represents an L-configurational carbon atom; or the pharmaceutically acceptable salt thereof. These compounds have a strong inhibitory effect on human renin, and are useful as a therapeutically active agent for the treatment of hypertension, especially renin - associated hypertension.

  @ 描述了由式表示的二肽 其中 His 代表 L-组氨酰基，Ar 代表苯基、萘基或吲哚基，Ar2 代表苯基或萘基，X 代表化学键、-NHCO-、-CONH-、-CO-、-CH2-、-NH-、-O-或-(CH=CH)P-其中 p 为 1 或 2，Z 代表氧原子或 其中 R2 代表氢原子或与 R 结合形成化学键，m 和 n 可以相同或不同，各代表 0 至 3 的整数，但当 X 为化学键时，n 加 m 之和为 1 至 6，当 X 不是化学键时，n 加 m 之和为 1 至 4、当 X 不是化学键时，Y 代表化学键；当 X 是化学键时，Y 代表具有 1 至 3 个碳原子的亚烷基；R1 代表氢原子或与 R2 结合形成化学键；R3 代表甲酰基或羟甲基；R4 代表异丁基或苄基；C 代表 L 构型碳原子；或其药学上可接受的盐。 这些化合物对人体肾素有很强的抑制作用，可作为治疗高血压，特别是肾素相关性高血压的治疗活性剂。
• [EN] CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS CARBOXYLIQUES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
  申请人：CRYSTAX PHARMACEUTICALS S L

  公开号：WO2009080722A3

  公开（公告）日：2009-11-26
• Wagner-Jauregg; Arnold; Born, Chemische Berichte, 1939, vol. 72, p. 1551,1554
  作者：Wagner-Jauregg、Arnold、Born

  DOI：——

  日期：——
• Leuchs; Reinhart, Chemische Berichte, 1924, vol. 57, p. 1213
  作者：Leuchs、Reinhart

  DOI：——

  日期：——